US 2023/0143264 A1 · COMPOSITION HAVING IMPROVED VOLUNTARY ACCEPTANCE

Abstract

The present invention relates to the field of pharmaceutical compositions suitable for the oral administration of an active in animals. In particular, the present invention relates to a liquid drug-containing formulation and to the use thereof. The present invention further relates to the use of a liquid formulation aid composition comprising at least one natural oil of herbal origin in a liquid drug-containing formulation for improving the acceptance or voluntary acceptance of drug intake in animal.

Claims29

Dependent claims

A liquid drug-containing formulation comprising the following components

A) at least one drug, which is a hypoxia-inducible factor prolyl hydroxylase inhibitor,
B) at least one natural oil of herbal origin,
C) optionally at least one natural oil of animal origin, and
D) optionally at least one thickener.

1 more element

Dependencies are inferred from the claim text.

Facts

Application

17/916,195Filed 30 Mar 2021

Priority

EP 20167444.731 Mar 2020

Published

11 May 2023

Term ends

Not estimatedThe source records don’t support an estimate.

Classification9 codes

A61K 9/0095
Galenical forms not covered by A61K9/02 - A61K9/7023: drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets…
A61K 31/5377
1,4-Oxazines, e.g. morpholine: not condensed and containing further heterocyclic rings, e.g. timolol
A61K 9/0053
Galenical forms characterised by the site of application: mouth and digestive tract, i.e. intraoral and peroral administration
A61K 9/08
Medicinal preparations characterised by special physical form: solutions

Composition having improved voluntary acceptance

Life of this patent

Composition having improved voluntary acceptance

Life of this patent

Abstract

Claims29